APA (7th ed.) Citation

Q, L., L, Z., Y, M., J, M., M, Z., Z, L., & B, C. (2026). Superiority of high-dose cytarabine-based mobilisation over cyclophosphamide or plerixafor in primary CNS lymphoma. Annals of hematology, 105(4), . https://doi.org/10.1007/s00277-026-06749-z

Chicago Style (17th ed.) Citation

Q, Li, Zhu L, Ma Y, Ma J, Zhang M, Lin Z, and Chen B. "Superiority of High-dose Cytarabine-based Mobilisation over Cyclophosphamide or Plerixafor in Primary CNS Lymphoma." Annals of Hematology 105, no. 4 (2026). https://doi.org/10.1007/s00277-026-06749-z.

MLA (9th ed.) Citation

Q, Li, et al. "Superiority of High-dose Cytarabine-based Mobilisation over Cyclophosphamide or Plerixafor in Primary CNS Lymphoma." Annals of Hematology, vol. 105, no. 4, 2026, https://doi.org/10.1007/s00277-026-06749-z.